| Financial Year |
March 31 2023 |
| Monetary Funds |
2,074,482,877.88 |
| Held-for-trading Financial Assets |
128,866,342.87 |
| Notes Receivable |
-- |
| Accounts Receivable |
338,099,318.60 |
| Advances to Suppliers |
129,940,512.26 |
| Other Receivables |
908,308,208.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
2,836,049.00 |
| Dividend Receivable |
5,004,549.22 |
| Inventories |
22,045,790.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
157,712,778.00 |
| Total Current Assets |
3,759,455,828.55 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
43,027,879.63 |
| Investment Properties |
-- |
| Fixed Assetes |
191,664,702.31 |
| Under-construction Projects |
50,891,420.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
175,837,798.83 |
| R&D expenses |
-- |
| Goodwill |
17,330,780.76 |
| Long-Term Deferred and Prepaid Expenses |
1,194,672.98 |
| Deferred Income Tax Assets |
14,977,880.80 |
| Other Non-Current Assets |
1,000.00 |
| Sub-Total of Non-Current Assets |
795,664,601.51 |
| Total Assets |
4,555,120,430.06 |
| Short-Term Loans |
2,002,567,536.87 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
113,105,382.93 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
21,115,521.30 |
| Taxes Payable |
21,178,955.00 |
| Interest Payable |
2,988,749.13 |
| Dividend Payable |
-- |
| Other payables |
96,940,338.54 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
30,849,021.66 |
| Other Current Liabilities |
1,198,011.82 |
| Sub-Total of Current Liabilities |
2,340,261,402.77 |
| Long-term Loans |
7,636,020.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,723,797.12 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
23,410,957.29 |
| Total Liabilities |
2,363,672,360.06 |
| Paid-In Capital(Or Share Stock) |
138,101,429.00 |
| Capital Surplus |
483,521,981.17 |
| Surplus Reserve |
74,931,907.54 |
| LESS:Treasury Stock |
24,172,367.00 |
| Undistributed Profits |
1,454,258,663.45 |
| Minority Stockholder's Interest |
63,893,051.52 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,127,555,018.48 |
| Owner's Equity（Stockholder's Equity） |
2,191,448,070.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,555,120,430.06 |
